Krenosin
Krenosin is a medicine authorised by Swissmedic under authorisation number 51567. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 06 April 1992 and the authorisation is valid without a time limit. ATC code C01EB10 places the medicine in the group Cardiac therapy.
| Authorisation number | 51567 |
|---|---|
| Name | Krenosin |
| Full name | Krenosin, solution injectable |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | C01EB10 |
| First authorisation | 06 April 1992 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Krenosin, solution injectable | A | 06 April 1992 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 13 | 6 x 2 mL | Ampulle(n) | C01EB10 | 02.02.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Krenosin authorised in Switzerland?
Yes. Krenosin is authorised by Swissmedic under authorisation number 51567, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Krenosin have?
Krenosin is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Krenosin?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.